Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyl-phosphate mannosyltransferase subunit 3 (DPM3) is a regulatory and stabilizer subunit of the dolichol-phosphate mannose (DPM) synthase complex, a critical multi-protein enzyme in the endoplasmic reticulum required for synthesis of dolichol-phosphate mannose, an essential glycosyl donor for N-glycosylation and the production of glycosylphosphatidylinositol (GPI) anchors. The DPM3 protein tethers the catalytic subunit (DPM1) to the endoplasmic reticulum membrane. Disruption of DPM3 function impairs glycoprotein biosynthesis, leading to congenital disorders of glycosylation and certain forms of muscular dystrophy[1][2][8].
No approved or investigational drugs are described to act by targeting this molecule; mechanism relates to its biological enzymatic and stabilizer role
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyl-phosphate mannosyltransferase subunit 3 (DPM3).